Skip to main content

Advertisement

Log in

Diagnostic and treatment interventions for hypochondriasis in the neurology setting

  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

Many patients who present to neurology settings with somatic complaints have underlying fear of illness, anxiety, or depression. Hypochondriasis, which is one of the somatoform disorders, contributes to high use of services and frustration on the part of clinicians, because diagnostic and treatment interventions often fail. The challenges for clinicians include how to distinguish true somatic symptoms from those associated with fear or other psychiatric symptoms. Our goal is to provide the clinician with an integrated approach for the triage, assessment (history, screening tools, examination, and diagnostic tests), and treatment of these challenging patients. Recommendations are made regarding psychiatric consultation and comanagement between fields for complex patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Van den Heuvel OA, Veltman DJ, Groenewegen HJ, et al.: Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder and hypochondriasis. Arch Gen Psychiatry 2005, 62:922–933. Explores neuroanatomical underpinnings of hypochondriasis.

    Article  PubMed  Google Scholar 

  2. Diagnostic and Statistical Manual of Mental Disorders, edn 4. Training Revision. Washington, DC: American Psychiatric Association; 2002.

  3. Reuber M, Mitchell AJ, Howlett SJ, et al.: Functional symptoms in neurology: questions and answers. J Neurol Neurosurg Psychiatry 2005, 76:307–314. Overview of somatoform disorders for neurology.

    Article  PubMed  CAS  Google Scholar 

  4. Fink P, Hansen MS, Søndergaard L: Somatoform disorders among first-time referrals to a neurology service. Psychosomatics 2005, 46:540–548. Information on hypochondriasis specific to neurology.

    Article  PubMed  Google Scholar 

  5. Magarinos M, Zafar U, Nissenson K, et al.: Epidemiology and treatment of hypochondriasis. CNS Drugs 2002, 16:9–22.

    Article  PubMed  Google Scholar 

  6. Rode S, Slkovskis, Dowd H, et al.: Health anxiety levels in chronic pain clinic attenders. J Psychosom Res 2006, 60:155–161.

    Article  PubMed  Google Scholar 

  7. Barsky AJ, Ettner SL, Horsky J, et al.: Resource utilization of patients with hypochondriacal health anxiety and somatization. Med Care 2001, 39:705–715.

    Article  PubMed  CAS  Google Scholar 

  8. Barsky AJ, Wyshak G, Klerman GL: Psychiatric comorbidity in DSM-III-R hypochondriasis. Arch Gen Psychiatry 1992, 49:101–108.

    PubMed  CAS  Google Scholar 

  9. Hollander E, Neville D, Frenkel M, et al.: Body dysmorphic disorder: diagnostic issues and related disorders. Psychosomatics 1992, 33:156–165.

    PubMed  CAS  Google Scholar 

  10. Toft T, Fink P, Oernboel E, et al.: Mental disorders in primary care: prevalence and co-morbidity among disorders and results from the functional illness in primary care (FIP) study. Psychol Med 2005, 35:1175–1184. Contrast of neurology with primary care.

    Article  PubMed  Google Scholar 

  11. Noyes R, Watson DB, Carney CP, et al.: Risk factors for hypochondriacal concerns in a sample of military veterans. J Psychosom Res 2004, 57:529–539.

    Article  PubMed  Google Scholar 

  12. Applegate KL, Keefe FJ, Siegler IC, et al.: Does personality at college entry predict number of reported pain conditions at mid-life? A longitudinal study. J Pain 2005, 6:92–97.

    Article  PubMed  Google Scholar 

  13. Melley AH, Oltmanns TF, Turkheimer E: The Schedule for Nonadaptive and Adaptive Personality (SNAP): temporal stability and predictive validity of the diagnostic scales. Assessment 2002, 9:181–187.

    Article  PubMed  Google Scholar 

  14. Noyes R Jr, Watson DB, Letuchy EM, et al.: Relationship between hypochondriacal concerns and personality dimensions and traits in a military population. J Nerv Ment Dis 2005, 193:110–118.

    Article  PubMed  Google Scholar 

  15. Walker J, Vincent N, Furer P: Treatment preference in hypochondriasis. J Behav Ther Exp Psychiatry 1999, 30:251–258.

    Article  PubMed  CAS  Google Scholar 

  16. Kroenke K, Swindle R: Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosom 2000, 69:205–215.

    Article  PubMed  CAS  Google Scholar 

  17. Visser S, Bouman TK: The treatment of hypochondriasis: exposure plus response prevention vs cognitive therapy. Behav Res Ther 2001, 39:423–442. Review of psychosocial treatments.

    Article  PubMed  CAS  Google Scholar 

  18. Looper KJ, Kirmayer LJ: Behavioral medicine approaches to somatoform disorders. Consult Clin Psychol 2002, 70:810–827.

    Article  Google Scholar 

  19. Kellner R: Psychotherapeutic strategies in hypochondriasis: a clinical study. Am J Psychother 1982, 36:146–157. Resource on all treatments for hypochondriasis.

    PubMed  CAS  Google Scholar 

  20. House A: Hypochondriasis and related disorders. Assessment and management of patients referred for a psychiatric opinion. Gen Hosp Psychiatry 1989, 11:156–165.

    Article  PubMed  CAS  Google Scholar 

  21. Barsky AJ: Hypochondriasis. Medical management and psychiatric treatment. Psychosomatics 1996, 37:48–56.

    PubMed  CAS  Google Scholar 

  22. Bouman TK: A community-based psychoeducational group approach to hypochondriasis. Psychother Psychosom 2002, 71:326–332.

    Article  PubMed  Google Scholar 

  23. Lidbeck J: Group therapy for somatization disorders in primary care: maintenance of treatment goals of short cognitive-behavioural treatment one-and-a-halfyear follow-up. Acta Psychiatr Scand 2003, 107:449–456.

    Article  PubMed  CAS  Google Scholar 

  24. Ladee GA: Hypochondriacal Syndromes. New York: Elsevier; 1966.

    Google Scholar 

  25. Fink P, Ornbol E, Toft T, et al.: A new, empirically established hypochondriasis diagnosis. Am J Psychiatry 2004, 161:1680–1691.

    Article  PubMed  Google Scholar 

  26. Hirschfeld RMA, Mallinckrofodt C, Lee TC, et al.: Time course of depression-symptom improvement during treatment with duloxetine. Depr Anxiety 2005, 21:170–177.

    Article  CAS  Google Scholar 

  27. Kellner R, Abbott P, Pathak D, et al.: Hypochondriacal beliefs and attitudes in family practice and psychiatric patients. Int J Psychiatry Med 1983–84, 13:127–139.

    Article  PubMed  Google Scholar 

  28. Speckens AEM, Spinhoven P, Sloekers PPA, et al.: A validation study of the Whitely Index, the Illness Attitude Scale, and the Somatosensory Amplification Scale in general medical and general practice patients. J Psychosom Res 1996, 40:95–104.

    Article  PubMed  CAS  Google Scholar 

  29. Janca A, Isaac M, Costae Silva JA: World Health Organization International Study of Somatoform Disorders: background and rationale. Eur J Psychiatry 1995, 9:100–110.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hilty, D.M., Bourgeois, J.A. & Chang, C.H. Diagnostic and treatment interventions for hypochondriasis in the neurology setting. Curr Treat Options Neurol 8, 401–409 (2006). https://doi.org/10.1007/s11940-006-0029-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-006-0029-3

Keywords

Navigation